Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $31.7200 (5.17%) ($29.6400 - $36.9200) on Thu. May. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.89% (three month average) | RSI | 30 | Latest Price | $31.7200(5.17%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN declines -10.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) QQQ(27%) XLC(27%) SKYY(24%) IBB(23%) IPO(23%) | Factors Impacting SONN price | SONN will decline at least -2.945% in a week (0% probabilities). VCSH(-32%) TLT(-25%) LQD(-25%) CEMB(-23%) VCIT(-18%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.945% (StdDev 5.89%) | Hourly BBV | 0 () | Intraday Trend | 7% | | | |
|
1 - 5 Day Possible Target | $2.75(-91.33%) | Resistance Level | $34.61 | 5 Day Moving Average | $29.74(6.66%) | 10 Day Moving Average | $30.52(3.93%) | 20 Day Moving Average | $34.61(-8.35%) | To recent high | -39% | To recent low | 16.2% | Market Cap | $292m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |